Press Releases

U.S. patent issues for gene expression profiles associated with chronic kidney allograft rejection, licensed exclusively to Transplant Genomics Inc.

09-29-2017

Genomic Signature for Predicting Acute Rejection in Liver Transplant Patients to be Presented at the American Transplant Congress

May 1, 2017

Transplant Genomics enters collaboration with Mayo Clinic

June 27, 2016

Transplant Genomics Announces Immunosuppressive Clinical Trials Collaboration with Astellas Pharmaceuticals

May 2, 2016

Transplant Genomics® and Quark Pharmaceuticals Announce Discovery and Development Collaboration

April 14, 2016

Transplant Genomics Announces Expansion of Scientific Advisory Board

January 11, 2016

Transplant Genomics Announces First Four Transplant Centers Participating in TruGraf Early Access Program

December 17, 2015

Transplant Genomics Inc. Supports First ASTS Faculty Research Grant for Biomarker Discovery and Functional Genomics

May 5, 2015

Dr. Roy First Joins Transplant Genomics as Chief Medical Officer

April 30, 2015

Studies Presented at American Transplant Congress Describe Validation of Noninvasive Tests for Post-Transplant Management of Kidney Graft Recipients

April 23, 2015

Transplant Genomics Appoints Brett Jensen Vice President of Sales

November 12, 2014

Studies Presented at World Transplant Congress Support Development of Biomarker Tests Aimed at Improving Transplant Recipient Care

July 28, 2014

Transplant Genomics Inc. Announces Exclusive License to Patent Rights Co-Owned by The Scripps Research Institute and Northwestern University

July 10, 2014